These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 13676712)

  • 1. [Paper chromatographic studies of the blood in tumors of the brain].
    KRUMBHOLZ S
    Zentralbl Chir; 1959 Jun; 84(25):978-85. PubMed ID: 13676712
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of lipids in middle molecular weight fractions as a feature of the pathological process].
    Promyslov MSh; Levchenko LI; Demchuk ML; Gabriélian NI
    Vopr Med Khim; 1989; 35(4):105-7. PubMed ID: 2815664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood picture changes in brain tumors].
    BRILMAYER H; AUF DER HAAR K
    Zentralbl Neurochir; 1957; 17(5):288-95. PubMed ID: 13544529
    [No Abstract]   [Full Text] [Related]  

  • 4. [Properdin content of the blood serum in tumors and flammatory diseases of the brain].
    Grinberg SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):857-8. PubMed ID: 5050042
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pre- and postoperative changes of blood picture in tumors of the greater hemispheres].
    BURGMAN GP; BIRIUKOVA LF
    Vopr Neirokhir; 1956; 20(6):14-20. PubMed ID: 13409784
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors.
    Fine RL; Chen J; Balmaceda C; Bruce JN; Huang M; Desai M; Sisti MB; McKhann GM; Goodman RR; Bertino JS; Nafziger AN; Fetell MR
    Clin Cancer Res; 2006 Oct; 12(19):5770-6. PubMed ID: 17020983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reactive changes in the blood in persons with brain lesions].
    Kozyrev VA
    Klin Med (Mosk); 1970 Sep; 48(9):97-103. PubMed ID: 5491703
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reactions of blood proteins in brain tumors, analyzed by paper electrophoresis].
    MANNIRONI G
    Rass Studi Psichiatr; 1956; 45(3):658-68. PubMed ID: 13359756
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
    Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
    Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma antioxidant vitamins in brain tumors.
    Rao GM; Rao AV; Raja A; Rao S; Rao A
    Neurol India; 2003 Jun; 51(2):220-2. PubMed ID: 14571008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, blinded analysis of A-PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors.
    Manley P; Li X; Turner C; Chi S; Zimmerman MA; Chordas C; Gordon A; Baker A; Ullrich NJ; Goumnerova L; Marcus K; Hoffman K; Kieran MW
    Pediatr Blood Cancer; 2009 Sep; 53(3):343-7. PubMed ID: 19422022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [BOLD-fMRI in sensory area and motor hand functional area with brain tumor in the central area].
    Zhou GF; Wang XY; Huang MP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):576-81. PubMed ID: 18667768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ABO blood group system to intracranial tumours--a study from South India.
    Sundar P; Malini AV; Radha RK; Sangeetha SK; Subba Krishna DK; Shankar SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):473-5. PubMed ID: 17001929
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histochemistry of lipid complexes in intracranial tumors].
    Curri SB; Costantini FE; Carteri A
    Minerva Neurochir; 1965; 9(1):52-5. PubMed ID: 5856703
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of human brain tissue, brain tumors and tumor cells by infrared spectroscopic mapping.
    Krafft C; Sobottka SB; Schackert G; Salzer R
    Analyst; 2004 Oct; 129(10):921-5. PubMed ID: 15457324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.
    Vogelbaum MA; Masaryk T; Mazzone P; Mekhail T; Fazio V; McCartney S; Marchi N; Kanner A; Janigro D
    Cancer; 2005 Aug; 104(4):817-24. PubMed ID: 15971200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The serum glycolipoprotein picture in relation to the nature of endocranial neoplasms].
    GIANNINI V; CALVARIO M; FIORE C
    G Psichiatr Neuropatol; 1960; 88():989-93. PubMed ID: 13705021
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
    Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
    Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model.
    Cardoso RC; Lobão-Soares B; Bianchin MM; Carlotti CG; Walz R; Alvarez-Silva M; Trentin AG; Nicolau M
    BMC Neurosci; 2004 Sep; 5():38. PubMed ID: 15458573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.